US$ 20.59
melanotan 2 effets secondaires Warning issued over increased use of 'Barbie drug' Melanotan-2 10mg — MT-II analogue
Description
Rituximab is licensed for the treatment of lymphomas, leukemias, transplant rejection crisis, and a series of autoimmune diseases (103, 104)

Conversely, LC-MS provides more structural information through MS/MS fragmentation of intact molecules

The mt2 10mg research peptide is the appropriate compound for broad melanocortin system investigations where multi-receptor pathway activation is the research objective

Nutraceuticals: Opening the debate for a regulatory framework
